Abiopharma

Zevra Therapeutics to Present at the J.P. Morgan 44th Annual Healthcare Conference

Acrivon Therapeutics Announces Positive ACR-368 Phase 2b Endometrial Cancer Clinical Data with EU Expansion to Accelerate Enrollment, Initial ACR-2316 Clinical Data, and ACR-6840, its Next AP3-Enabled Development Candidate, Targeting CDK11

Anavex Life Sciences Appoints Senior Vice President Global Head of Neurology

(85% Positive) ENTRADA THERAPEUTICS, INC. (TRDA) Announces Clinical Development Update

Indivior Notification

(90% Positive) CULLINAN THERAPEUTICS, INC. (CGEM) Announces Enrollment Update for dosing Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

(90% Positive) Opus Genetics, Inc. (OCUP) Announces Enrollment Update for qualify Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

(80% Positive) Invivyd, Inc. (IVVD) Announces Enrollment Update for preparing Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

(10% Negative) Standard BioTools Inc. (LAB) Announces Business Combination

(90% Positive) VANDA PHARMACEUTICALS INC. (VNDA) Provides Update on effectiveness for Jet Lag DisorderJanuary 8

(90% Positive) CLIMB BIO, INC. (ELYM) Announces Enrollment Update for trial Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

Canopy Growth Communication - Canopy Growth Announces Strategic Recapitalization Transactions Significantly Strengthening Balance Sheet to Support Growth Strategy

(90% Positive) AMARIN CORP PLC\UK (AMRN) Provides Update on meetings for our operating expenses

(10% Negative) AMYLYX PHARMACEUTICALS, INC. (AMLX) Files Form 8-K

(10% Negative) Neogen Corporation (NEOG) Reports Q1 2026 Financial Results